157 related articles for article (PubMed ID: 32935088)
1. How mu-Opioid Receptor Recognizes Fentanyl.
Vo QN; Mahinthichaichan P; Shen J; Ellis CR
Res Sq; 2020 Sep; ():. PubMed ID: 32935088
[TBL] [Abstract][Full Text] [Related]
2. How
Vo QN; Mahinthichaichan P; Shen J; Ellis CR
bioRxiv; 2020 Nov; ():. PubMed ID: 32839778
[TBL] [Abstract][Full Text] [Related]
3. How μ-opioid receptor recognizes fentanyl.
Vo QN; Mahinthichaichan P; Shen J; Ellis CR
Nat Commun; 2021 Feb; 12(1):984. PubMed ID: 33579956
[TBL] [Abstract][Full Text] [Related]
4. Kinetics and Mechanism of Fentanyl Dissociation from the μ-Opioid Receptor.
Mahinthichaichan P; Vo QN; Ellis CR; Shen J
JACS Au; 2021 Dec; 1(12):2208-2215. PubMed ID: 34977892
[TBL] [Abstract][Full Text] [Related]
5. Fentanyl and the Fluorinated Fentanyl Derivative NFEPP Elicit Distinct Hydrogen-Bond Dynamics of the Opioid Receptor.
Lešnik S; Bren U; Domratcheva T; Bondar AN
J Chem Inf Model; 2023 Aug; 63(15):4732-4748. PubMed ID: 37498626
[TBL] [Abstract][Full Text] [Related]
6. Modulation of μ-opioid receptor activation by acidic pH is dependent on ligand structure and an ionizable amino acid residue.
Meyer J; Del Vecchio G; Seitz V; Massaly N; Stein C
Br J Pharmacol; 2019 Dec; 176(23):4510-4520. PubMed ID: 31355457
[TBL] [Abstract][Full Text] [Related]
7. Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns.
Ricarte A; Dalton JAR; Giraldo J
J Chem Inf Model; 2021 Mar; 61(3):1251-1274. PubMed ID: 33448226
[TBL] [Abstract][Full Text] [Related]
8. Fentanyl-Type Antagonist of the μ-Opioid Receptor: Important Role of Axial Chirality in the Active Conformation.
Arita H; Tanaka R; Kikukawa S; Tomizawa T; Sakata H; Funada M; Tomiyama K; Hashimoto M; Tasaka T; Tabata H; Nakamura K; Makino K; Oshitari T; Natsugari H; Takahashi H
J Med Chem; 2024 Jun; 67(12):10447-10463. PubMed ID: 38869493
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive evaluation of the potential binding poses of fentanyl and its analogs at the µ-opioid receptor.
Xie B; Goldberg A; Shi L
Comput Struct Biotechnol J; 2022; 20():2309-2321. PubMed ID: 35615021
[TBL] [Abstract][Full Text] [Related]
10. Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors.
Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Nilsen A; Torralva R; Janowsky A
Biochem Pharmacol; 2020 Dec; 182():114293. PubMed ID: 33091380
[TBL] [Abstract][Full Text] [Related]
11.
Hiranita T; Ho NP; France CP
J Pharmacol Exp Ther; 2024 Feb; ():. PubMed ID: 38409115
[TBL] [Abstract][Full Text] [Related]
12. Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide.
Vandeputte MM; Tsai MM; Chen L; Glatfelter GC; Walther D; Stove CP; Shi L; Baumann MH
Drug Alcohol Depend; 2023 Aug; 249():109939. PubMed ID: 37276825
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML
Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective recognition of morphine enantiomers by
Wang Y; Ngo VA; Wang X
Natl Sci Rev; 2024 Mar; 11(3):nwae029. PubMed ID: 38410825
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine 7.43 is important for mu-opioid receptor downstream signaling pathways activated by fentanyl.
Tian X; Zhang J; Wang S; Gao H; Sun Y; Liu X; Fu W; Tan B; Su R
Front Pharmacol; 2022; 13():919325. PubMed ID: 36120357
[TBL] [Abstract][Full Text] [Related]
16. Alkoxy chain length governs the potency of 2-benzylbenzimidazole 'nitazene' opioids associated with human overdose.
Glatfelter GC; Vandeputte MM; Chen L; Walther D; Tsai MM; Shi L; Stove CP; Baumann MH
Psychopharmacology (Berl); 2023 Dec; 240(12):2573-2584. PubMed ID: 37658878
[TBL] [Abstract][Full Text] [Related]
17. Ligand-Free Signaling of G-Protein-Coupled Receptors: Relevance to μ Opioid Receptors in Analgesia and Addiction.
Sadee W; McKew JC
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144565
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid.
Vandeputte MM; Krotulski AJ; Walther D; Glatfelter GC; Papsun D; Walton SE; Logan BK; Baumann MH; Stove CP
Arch Toxicol; 2022 Jun; 96(6):1845-1863. PubMed ID: 35477798
[TBL] [Abstract][Full Text] [Related]
19. 'Carba'-carfentanil (trans isomer): a μ opioid receptor (MOR) partial agonist with a distinct binding mode.
Weltrowska G; Lemieux C; Chung NN; Guo JJ; Wilkes BC; Schiller PW
Bioorg Med Chem; 2014 Sep; 22(17):4581-6. PubMed ID: 25129170
[TBL] [Abstract][Full Text] [Related]
20. Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment.
Obeng S; Jali A; Zheng Y; Wang H; Schwienteck KL; Chen C; Stevens DL; Akbarali HI; Dewey WL; Banks ML; Liu-Chen LY; Selley DE; Zhang Y
ACS Chem Neurosci; 2019 May; 10(5):2518-2532. PubMed ID: 30758946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
